A detailed history of Johnson Investment Counsel Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 522,426 shares of ZTS stock, worth $86 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
522,426
Previous 529,649 1.36%
Holding current value
$86 Million
Previous $91.8 Million 11.17%
% of portfolio
1.01%
Previous 0.97%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$172.58 - $196.48 $1.25 Million - $1.42 Million
-7,223 Reduced 1.36%
522,426 $102 Million
Q2 2024

Aug 08, 2024

SELL
$145.54 - $178.83 $543,591 - $667,930
-3,735 Reduced 0.7%
529,649 $91.8 Million
Q1 2024

May 09, 2024

SELL
$165.67 - $199.94 $2.9 Million - $3.5 Million
-17,486 Reduced 3.17%
533,384 $90.3 Million
Q4 2023

Feb 07, 2024

SELL
$151.44 - $200.09 $3.87 Million - $5.12 Million
-25,576 Reduced 4.44%
550,870 $109 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $8.94 Million - $10.3 Million
-53,492 Reduced 8.49%
576,446 $100 Million
Q2 2023

Aug 10, 2023

SELL
$160.94 - $186.23 $3.97 Million - $4.59 Million
-24,664 Reduced 3.77%
629,938 $108 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $1.56 Million - $1.87 Million
-10,693 Reduced 1.61%
654,602 $109 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $4.91 Million - $5.89 Million
37,431 Added 5.96%
665,295 $97.5 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $1.9 Million - $2.34 Million
12,816 Added 2.08%
627,864 $93.1 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $3.13 Million - $4.02 Million
20,073 Added 3.37%
615,048 $106 Million
Q1 2022

May 11, 2022

BUY
$181.39 - $234.03 $1.65 Million - $2.13 Million
9,107 Added 1.55%
594,975 $112 Million
Q4 2021

Feb 15, 2022

SELL
$193.69 - $247.03 $2.04 Million - $2.6 Million
-10,518 Reduced 1.76%
585,868 $143 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $267,277 - $296,082
1,412 Added 0.24%
596,386 $116 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $359,193 - $433,128
2,304 Added 0.39%
594,974 $111 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $2.4 Million - $2.82 Million
16,668 Added 2.89%
592,670 $93.3 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $114,346 - $126,926
-728 Reduced 0.13%
576,002 $95.3 Million
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $2.95 Million - $3.55 Million
-21,484 Reduced 3.59%
576,730 $95.4 Million
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $70.4 Million - $89.7 Million
-629,324 Reduced 51.27%
598,214 $82 Million
Q1 2020

May 20, 2020

BUY
$92.66 - $144.94 $55.7 Million - $87.2 Million
601,406 Added 96.05%
1,227,538 $154 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $8,718 - $9,993
-75 Reduced 0.01%
626,132 $82.9 Million
Q3 2019

Nov 14, 2019

SELL
$112.57 - $128.43 $1.69 Million - $1.93 Million
-15,026 Reduced 2.34%
626,207 $78 Million
Q2 2019

Aug 14, 2019

SELL
$97.98 - $114.28 $668,223 - $779,389
-6,820 Reduced 1.05%
641,233 $72.8 Million
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $1.41 Million - $1.74 Million
17,259 Added 2.74%
648,053 $65.2 Million
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $991,792 - $1.19 Million
-12,510 Reduced 1.94%
630,794 $54 Million
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $417,500 - $466,150
-5,000 Reduced 0.77%
643,304 $58.9 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $1.17 Million - $1.3 Million
-14,592 Reduced 2.2%
648,304 $55.2 Million
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $1.83 Million - $2.17 Million
-25,607 Reduced 3.72%
662,896 $55.4 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $2.45 Million - $2.82 Million
-38,707 Reduced 5.32%
688,503 $49.6 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $43.4 Million - $47.6 Million
727,210
727,210 $46.4 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.